Sask. COVID-19: Two new deaths, 48 new cases, 79 more recoveries announced Monday

The Saskatchewan government has announced two new deaths from residents who tested positive for COVID-19 on Monday.

Both residents who died were in the 80-plus age group. One death was reported in the North Central zone, while the other death was reported in the North West zone.

There are also 48 new cases and 79 more recoveries in Saskatchewan as of Monday. New cases are located in the following zones: Far North West, five; Far North East, one; North West, three; North Central, 10; Saskatoon, six; Central West, two; Regina, 15; South Central, three; and South East, one.

(Photo: Government of Saskatchewan)

Active cases are at 711 with the seven-day average of new COVID-19 case number at 69.

Hospitalizations are at 76, which is the lowest number of hospitalizations since November 18, 2020. Inpatient care numbers are at 65 while 11 people are in intensive care.

To date, 902,790 COVID-19 tests have been processed in Saskatchewan. An additional 961 vaccinations administered in Saskatchewan, bringing the total number of vaccines administered in the province to 998,779.

As of June 20, 11,971 variants of concern have been identified by screening in Saskatchewan, reported in the following zones: Far North West, 291; Far North Central, 1; Far North East, 84; North West, 777; North Central, 616; North East, 79; Saskatoon, 2,079; Central West, 145; Central East, 641; Regina, 4,774; South West, 400; South Central, 885; and South East, 1,127.

Zero new lineage results were reported for Variants of Concern on Monday. Of the 6,814 VOCs with lineages identified by whole genome sequencing in Saskatchewan, 6,417 are Alpha (B.1.1.7), 282 are Gamma (P.1), 105 are Delta (B.1.617.2) and 10 are Beta (B.1.351).

Eligibility for second doses expands

Anyone who received their first dose on or before May 15 is eligible for their second vaccine starting Monday. Second doses are also available in the Northern Saskatchewan Administration District to all residents 18+, based on the product’s recommended interval from their first dose.

A limited number of first doses of AstraZeneca have been administered since May 5 to those individuals who have contraindication for mRNA vaccines. Residents who received AstraZeneca after May 5 will have arrangements in place to administer the second dose based on current, recommended intervals.

Eligibility for 2nd Dose of COVID-19 Vaccine
    1st Dose Date 
(on or before)
Eligible for 2nd Dose (on or after)
  May 15 June 21
   Everyone age 12+, receiving 2nd dose after 28 days June 24

When all persons 12 and older become eligible to receive their second doses starting June 24, second doses can be completed any time after 28 days.  With the Delta variant circulating in Saskatchewan, it remains recommended that all residents receive second dose vaccinations as soon as they are eligible.

More from Play92